Study Using the Environmental Exposure Chamber (EEC) to Assess the Onset of Action of Ciclesonide, Applied as a Nasal Spray in Treatment of Seasonal Allergic Rhinitis (BY9010/M1-406)

NCT00659594 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhinitis, Allergic, Seasonal
Hay Fever

Interventions

DRUG: Ciclesonide
DRUG: Placebo

Sponsor

AstraZeneca